Natasha Clinton, MSN, APRN, AOCNP, BCMAS

home / authors / natasha-clinton-msn-aprn-aocnp-bcmas

Articles

Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies

Kashyap Patel, MD;Hirangi Mukhi, BS;Anjana Patel, BSc;Dhwani Mehta, MS;Natasha Clinton, MSN, APRN, AOCNP, BCMAS;Ben Brown;Sara Rogers, PharmD;William Oh, MD;Prasanth Reddy, MD, MPH

February 14th 2022

Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.

The Role of In-Office Next Generation Sequencing to Advance Precision Medicine in Community Oncology

Kashyap Patel, MD;Natasha Clinton, MSN, APRN, AOCNP, BCMAS;Hirangi Mukhi, BS;Maharshi Patel, BS, MBA

May 13th 2021

The goal of precision medicine is to advance medical and scientific discoveries to offer more tailored, precise, and accurate health interventions to maximize the health benefits for patients.

COVID-19 Presents an Opportunity for Precision Medicine to Play Expanded Role in Care

Kashyap Patel, MD;Natasha Clinton, MSN, APRN, AOCNP, BCMAS;Hirangi Mukhi, BS;Maharshi Patel, BS, MBA

May 22nd 2020

"We recommend following an assessment for patients with cancer and treatment priority determination that would assist in the management of these patients."